سوق العلاج بالخلايا التائية في السيارة – السائقين والاتجاهات والفرص وإحصاءات النمو | 2031

Publication Month : Feb 2024

  • Report Code : TIPRE00029935
  • Category : Biotechnology
  • Status : Data Released
  • No. of Pages : 150
Inquire Before Buy

PRICING

$5190

$4671

نظرة عامة على السوق

مستقبل المستضد الخيميري هو نوع فريد من المستقبلات (CAR) وهو نوع فريد من المستقبلات المستخدمة في علاج CAR T. في هذا العلاج، يتم إنشاء خلايا CAR-T بأعداد كبيرة في المختبر ثم يتم حقنها في المريض. يُستخدم علاج CAR T لعلاج أنواع معينة من الأورام الخبيثة في الدم، كما تتم دراسته أيضًا لعلاج أنواع أخرى من السرطان. ويُعرف أيضًا باسم العلاج بالخلايا التائية بمستقبلات المستضد الخيميري. تُستخدم الخلايا التائية في هذا العلاج لأنها مسؤولة عن تدمير الخلايا الخبيثة والمصابة بالفيروسات. يمكن أن تغطي الخلايا السرطانية الجهاز المناعي، لكن علاج CAR T أدى إلى تحسين قدرة الخلايا التائية على العثور على الخلايا السرطانية وتدميرها.

“تحليل سوق العلاج بالخلايا التائية CAR العالمي حتى عام 2028” هي دراسة متخصصة ومتعمقة لصناعة الأجهزة الطبية مع التركيز بشكل خاص على تحليل اتجاهات السوق العالمية. يهدف التقرير إلى تقديم نظرة عامة على سوق العلاج بالخلايا CAR T مع تجزئة السوق التفصيلية حسب نوع المنتج والمؤشر والمستخدم النهائي والجغرافيا. يقدم التقرير إحصائيات أساسية عن حالة السوق للاعبين الرائدين في سوق العلاج بالخلايا CAR T ويقدم الاتجاهات والفرص الرئيسية في السوق.

العوامل التي تدفع نمو سوق العلاج بالخلايا T CAR T هي ارتفاع معدل انتشار السرطان وخط أنابيب قوي للمنتجات، وزيادة الطلب على العلاجات المثالية لعلاج السرطان، وزيادة الوعي. الطب العلاجي بالخلايا التائية CAR. ومع ذلك، فإن عواقب العلاج بالخلايا التائية الخيمرية وارتفاع أسعار إنتاج العلاج بالخلايا التائية الخيمرية هي العوامل التي تقيد نمو سوق العلاج بالخلايا التائية الخيمرية.

Intellia Therapeutics

  • جونسون آند جونسون
  • ميريك KGAA
  • Curocell, Inc.
  • Stempeutics Research PVT LTD
  • Novartis AG

    التطورات الأخيرة

    • في مايو 2021، أعلنت شركة Novartis عن T-Charge، وهي منصة CAR-T من الجيل التالي تحتوي على بيانات أولية على الإنسان في ASH 2021 والتي تهدف إلى تغيير علاج CAR-T وستعمل كأساس لمجموعة متنوعة من علاجات CAR-T التجريبية.
    • في فبراير 2022، أعلنت شركة Johnson & Johnson، وهي شركة رائدة في مجال الرعاية الصحية، أن CARVYKTI (ciltcabtagene autoleucel)، وهو علاج مناعي CAR-T موجه بواسطة BCMA، قد تمت الموافقة عليه من قبل إدارة الغذاء والدواء الأمريكية لـ التعامل مع المرضى الذين يعانون من المايلوما المتعددة الانتكاسية أو المقاومة.
    • في أبريل 2023، حصلت شركة Caribou Biosciences على تصنيف المسار السريع من قبل إدارة الغذاء والدواء الأمريكية لعلاجها بالخلايا CART، CB011. العلاج قيد التطوير حاليًا لعلاج المرضى الذين يعانون من الانتكاسات أو المقاومة. المايلوما المتعددة (r/r MM). تجري شركة كاريبو حاليًا دراسة المرحلة الأولى من CaMMouflage لتقييم CB011 في مرضى rMMr. يتم تضمين المرضى عند مستوى الجرعة الأولى في هذه الدراسة. ومن المتوقع أيضًا توفير اتصالات مبكرة ومستمرة من الولايات المتحدة إدارة الغذاء والدواء مع Caribou في عملية المراجعة التنظيمية.

    يتكون فريق البحث والتحليل المخصص التابع لشركة Insight Partner من محترفين ذوي خبرة يتمتعون بخبرة إحصائية متقدمة ويقدمون خيارات تخصيص متنوعة في الدراسة الحالية.

  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    Which are the top companies that hold the market share in CAR-T cell therapy market?

    Gilead Sciences, Inc and Bristol Myers Squibb are the top two companies that hold huge market shares in the CAR-T cell therapy market.

    Which region is expected to witness significant demand for CAR-T cell therapy market in the coming years?

    Global CAR-T cell therapy market is segmented by region into North America, Europe, Asia Pacific, Rest of World. North America held the largest market share of the CAR-T cell therapy market in 2022.

    Who are the key players in the CAR-T cell therapy market?

    The CAR-T cell therapy market majorly consists of the players such Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences, Inc., Johnson & Johnson Services, Inc., CARsgenTherapeutics Co., Ltd, Aurora Biopharma, Legend Biotech, Pfizer Inc., bluebird bio, Inc., Mustang Bio, Sorrento Therapeutics, Inc., and Fate Therapeutics, and amongst others.

    Which application segment held the largest share in the CAR-T cell therapy market?

    The Lymphomas segment dominated the global CAR-T cell therapy market and held the largest market share in 2022.

    Which product segment leads the CAR-T cell therapy market?

    The CD19 segment held the largest share of the market in the global CAR-T cell therapy market and held the largest market share in 2022.

    What is the market CAGR value of CAR-T cell therapy market during forecast period?

    The CAGR value of the CAR-T cell therapy market during the forecasted period of 2022-2030 is 17.5%s

    What are the driving factors for the CAR-T cell therapy market across the globe?

    Key factors that are driving the growth of this market are new product approvals and increase in prevalence of cancer is expected to boost the market growth for the CAR-T cell therapy over the years.

    What is CAR-T cell therapy market?

    Chimeric antigen receptor (CAR)-T cell therapy is a kind of cancer immunotherapy treatment that makes use of T cells, which are immune cells, that have undergone genetic alteration in a lab to improve their ability to recognize and eliminate cancer cells. CAR-T cell therapy is one of the newest and most promising treatments for blood cancer.

    The List of Companies - CAR-T Cell Therapy Market

    1. Bristol-Myers Squibb Company
    2. Novartis AG
    3. Gilead Sciences, Inc.
    4. Johnson & Johnson Services, Inc.
    5. CARsgenTherapeutics Co., Ltd
    6. Aurora Biopharma
    7. Legend Biotech
    8. Pfizer Inc.
    9. bluebird bio, Inc.
    10. Mustang Bio
    11. Sorrento Therapeutics, Inc
    12. Fate Therapeutics

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports